{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:39:29Z","timestamp":1790516369918,"version":"4.1.0"},"reference-count":0,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2003,10,30]],"date-time":"2003-10-30T00:00:00Z","timestamp":1067472000000},"content-version":"vor","delay-in-days":2342,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[1997,6]]},"abstract":"<jats:p>Phagocytosis is a fundamental process in innate resistance to infection. We have used the pathogenic yeast <jats:italic>Cryptococcus neoformans<\/jats:italic> to study the interaction of this encapsulated organism with murine macrophages <jats:italic>in vitro<\/jats:italic>. In the absence of exogenous opsonins the encapsulated yeast is almost totally resistant to ingestion by murine macrophages. Owing to its ability to activate the alternative complement pathway, the anti\u2010phagocytic properties of the polysaccharide capsule can be partially overcome following opsonization <jats:italic>in vitro<\/jats:italic> with non\u2010immune mouse serum and subsequent phagocytosis via complement receptors. Here, we demonstrate the importance of the complement receptor type 3 (CR3) in <jats:italic>in vitro<\/jats:italic> phagocytosis of the yeast and in <jats:italic>in vivo<\/jats:italic> resistance to infection. <jats:italic>In vitro<\/jats:italic>, 70% of a population of resident murine macrophages are able to ingest <jats:italic>C. neoformans<\/jats:italic> and then only inefficiently (1\u20132 organisms per cell). Previously we have shown that tumour necrosis factor\u2010<jats:italic>\u03b1<\/jats:italic> (TNF\u2010<jats:italic>\u03b1<\/jats:italic>) and granulocyte\u2013macrophage colony\u2010stimulating factor (GM\u2010CSF) efficiently enhance ingestion of serum\u2010opsonized encapsulated <jats:italic>C. neoformans<\/jats:italic>, and we now show that the cytokines convert a population of resident macrophages to a state where all the cells are competent for ingestion of large numbers of yeasts (6\u20138 per cell). We also show that these cytokines have a direct effect on CR3, as enhanced levels of complement\u2010opsonized sheep red blood cells (EIgMC) bind to macrophages activated in this way. However, cytokines that have previously been shown to enhance phagocytosis of EIgMC have no effect on ingestion of encapsulated <jats:italic>C. neoformans<\/jats:italic>. These results demonstrate that the cytokines regulating CR3\u2010dependent ingestion of <jats:italic>C. neoformans<\/jats:italic> are different to those regulating ingestion of EIgMC and reinforce the importance of studying pathogens rather than inert ligands in understanding the regulation of phagocytosis.<\/jats:p>","DOI":"10.1046\/j.1365-2567.1997.00238.x","type":"journal-article","created":{"date-parts":[[2003,11,2]],"date-time":"2003-11-02T15:45:30Z","timestamp":1067787930000},"page":"289-296","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["CR3\u2010dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement\u2010opsonized <i>Cryptococcus neoformans<\/i>"],"prefix":"10.1111","volume":"91","author":[{"given":"C. E.","family":"CROSS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. L.","family":"COLLINS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"BANCROFT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,10,30]]},"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2567.1997.00238.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2567.1997.00238.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2567.1997.00238.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T09:28:05Z","timestamp":1694424485000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2567.1997.00238.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["10.1046\/j.1365-2567.1997.00238.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2567.1997.00238.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6]]},"assertion":[{"value":"2003-10-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}